SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : North American Vaccine
NVX 1.510-3.8%Oct 31 9:30 AM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: andy harrison who wrote (74)11/13/1996 7:07:00 PM
From: Don W Stone   of 82
 
Andy, I went to three drug stores and Barnes & Noble and they are still selling the NOVEMBER issue. So if you are a subscriber you have the jump on us.
So that said , what does the article say, give us your synopsis.
My understanding is that they are supporting the CDC decision to switch from oral to injectible to elliminate polio completely in this country.
Now, that to me is very nice indirect PR with NVX having just recently gotten their approval for, the only one of its kind, vaccine in the world, DTaP-IPV, from Denmark. And NVX is projecting availablilty in the US of as early as Late '97 , to Jan.'98.
The market should be really primed by then. :-}...
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext